Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H M Shepard

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
The Journal of Experimental Medicine|January 1, 1992
Development of humanized bispecific antibodies reactive with cytotoxic lymphocytes and tumor cells overexpressing the HER2 protooncogeneM R Shalaby, H M Shepard, L Presta, et al.
DNA (Mary Ann Liebert, Inc.)|January 1, 1982
Carboxyterminal region of hybrid leukocyte interferons affects antiviral specificityA E Franke, H M Shepard, C M Houck, et al.
Nucleic Acids Research|November 25, 1981
Antiviral activities of hybrids of two major human leukocyte interferonsP K Weck, S Apperson, N Stebbing, et al.
Science (New York, N.Y.)|November 22, 1985
Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitroB J Sugarman, B B Aggarwal, P E Hass, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1988
Amplified expression of the HER2/ERBB2 oncogene induces resistance to tumor necrosis factor alpha in NIH 3T3 cellsR M Hudziak, G D Lewis, M R Shalaby, et al.
Cancer Treatment and Research|January 1, 1992
Anti-p185HER2 monoclonal antibodies: biological properties and potential for immunotherapyJ W Park, R Stagg, G D Lewis, et al.
Blood|June 15, 1996
Gene transfer into human bone marrow hematopoietic cells mediated by adenovirus vectorsT Watanabe, C Kuszynski, K Ino, et al.
The Journal of Experimental Medicine|August 1, 1987
Inhibition of cytokine production by cyclosporin A and transforming growth factor betaT Espevik, I S Figari, M R Shalaby, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1987
Tumor necrosis factors alpha and beta differ in their capacities to generate interleukin 1 release from human endothelial cellsR M Locksley, F P Heinzel, H M Shepard, et al.
Journal of Leukocyte Biology|March 1, 1987
Receptor binding and activation of polymorphonuclear neutrophils by tumor necrosis factor-alphaM R Shalaby, M A Palladino, S E Hirabayashi, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
The Journal of Experimental Medicine|January 1, 1992
Development of humanized bispecific antibodies reactive with cytotoxic lymphocytes and tumor cells overexpressing the HER2 protooncogeneM R Shalaby, H M Shepard, L Presta, et al.
DNA (Mary Ann Liebert, Inc.)|January 1, 1982
Carboxyterminal region of hybrid leukocyte interferons affects antiviral specificityA E Franke, H M Shepard, C M Houck, et al.
Nucleic Acids Research|November 25, 1981
Antiviral activities of hybrids of two major human leukocyte interferonsP K Weck, S Apperson, N Stebbing, et al.
Science (New York, N.Y.)|November 22, 1985
Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitroB J Sugarman, B B Aggarwal, P E Hass, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1988
Amplified expression of the HER2/ERBB2 oncogene induces resistance to tumor necrosis factor alpha in NIH 3T3 cellsR M Hudziak, G D Lewis, M R Shalaby, et al.
Cancer Treatment and Research|January 1, 1992
Anti-p185HER2 monoclonal antibodies: biological properties and potential for immunotherapyJ W Park, R Stagg, G D Lewis, et al.
Blood|June 15, 1996
Gene transfer into human bone marrow hematopoietic cells mediated by adenovirus vectorsT Watanabe, C Kuszynski, K Ino, et al.
The Journal of Experimental Medicine|August 1, 1987
Inhibition of cytokine production by cyclosporin A and transforming growth factor betaT Espevik, I S Figari, M R Shalaby, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1987
Tumor necrosis factors alpha and beta differ in their capacities to generate interleukin 1 release from human endothelial cellsR M Locksley, F P Heinzel, H M Shepard, et al.
Journal of Leukocyte Biology|March 1, 1987
Receptor binding and activation of polymorphonuclear neutrophils by tumor necrosis factor-alphaM R Shalaby, M A Palladino, S E Hirabayashi, et al.
Pageof 6